Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Cortes

Showing results (511-520 of 713) with videos related to

Pageof 72
Sort By:
Leukemia & Lymphoma|September 6, 2013
Mutated NPM1 in patients with acute myeloid leukemia in remission and relapsePreetesh Jain, Hagop Kantarjian, Keyur Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar, et al.
Blood|July 1, 2015
Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinibKeyur P Patel, Kate J Newberry, Rajyalakshmi Luthra, et al.
Blood|December 13, 2006
Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 studySteven M Kornblau, Deborah E Banker, Derek Stirewalt, et al.
Cancer|January 28, 2004
Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapyGloria N Mattiuzzi, Hagop Kantarjian, Susan O'Brien, et al.
Plos One|March 26, 2013
Epidemiology of candidemia in Latin America: a laboratory-based surveyMarcio Nucci, Flavio Queiroz-Telles, Tito Alvarado-Matute, et al.
Science Translational Medicine|September 9, 2016
Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cellsBing Z Carter, Po Yee Mak, Hong Mu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancersHagop M Kantarjian, Varsha Gandhi, Peter Kozuch, et al.
American Journal of Hematology|April 22, 2011
Prediction model for mortality after intracranial hemorrhage in patients with leukemiaFarshid Dayyani, Sarah Schellhorn Mougalian, Kiran Naqvi, et al.
Blood|June 5, 2004
Outcome with the hyper-CVAD regimens in lymphoblastic lymphomaDeborah A Thomas, Susan O'Brien, Jorge Cortes, et al.
Pageof 72

Showing results (511-520 of 713) with videos related to

Sort By:
Pageof 72
Leukemia & Lymphoma|September 6, 2013
Mutated NPM1 in patients with acute myeloid leukemia in remission and relapsePreetesh Jain, Hagop Kantarjian, Keyur Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar, et al.
Blood|July 1, 2015
Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinibKeyur P Patel, Kate J Newberry, Rajyalakshmi Luthra, et al.
Blood|December 13, 2006
Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 studySteven M Kornblau, Deborah E Banker, Derek Stirewalt, et al.
Cancer|January 28, 2004
Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapyGloria N Mattiuzzi, Hagop Kantarjian, Susan O'Brien, et al.
Plos One|March 26, 2013
Epidemiology of candidemia in Latin America: a laboratory-based surveyMarcio Nucci, Flavio Queiroz-Telles, Tito Alvarado-Matute, et al.
Science Translational Medicine|September 9, 2016
Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cellsBing Z Carter, Po Yee Mak, Hong Mu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancersHagop M Kantarjian, Varsha Gandhi, Peter Kozuch, et al.
American Journal of Hematology|April 22, 2011
Prediction model for mortality after intracranial hemorrhage in patients with leukemiaFarshid Dayyani, Sarah Schellhorn Mougalian, Kiran Naqvi, et al.
Blood|June 5, 2004
Outcome with the hyper-CVAD regimens in lymphoblastic lymphomaDeborah A Thomas, Susan O'Brien, Jorge Cortes, et al.
Pageof 72